Author: healthadmin

abstract In this real-world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received corbopasvir (60 mg) and sofosbuvir (400 mg) daily for 12 weeks. The overall SVR12 was 99.1% (112/113). SVR12 was 100% for genotypes 3a, 3b, 6a, and compensated cirrhosis, 93.3% for genotype 1b, and 90% for HBV co-infection. Liver function (ALBI) and fibrosis scores (FIB-4, APRI) were significantly improved. No serious adverse events occurred. The corbopasvir + sofosbuvir regimen demonstrated excellent efficacy and safety across a variety of genotypes (including hard-to-treat genotype 3b) and comorbidities. introduction Chronic HCV is the main cause of liver cirrhosis and HCC…

Read More

New research at this year’s European Congress on Obesity (ECO 2026) argues that understanding how obesity has been depicted in art through the ages should make doctors more empathetic and less judgmental, leading to better outcomes for patients. Michael Yaffe, a pediatric endocrinologist at the University of Texas Health Science Center (UT Health) in Houston, Texas, also speculates that future art will feature the “GLP-1 face,” the haggard look that can occur when people lose large amounts of weight rapidly with GLP-1 drugs. Using examples from works of art spanning centuries, Dr. Yaffe explains how, until relatively recently, obesity was…

Read More

Researchers have proposed a new standard for the decades-old prosthetic donation market, improving the quality of lower limb prostheses by two-thirds and significantly improving the quality of life for recipients. A multidisciplinary team of charities, prosthetists and academics, led by King’s College London, designed and implemented the first set of standardized regulations for the export of prosthetic limbs to the Global South, reducing unusable donations from 16% to 5%. In doing so, the team laid the foundations for an ethical framework for improving the provision of prosthetic limbs in the UK and a first-of-its-kind global prosthetic circular economy. The…

Read More

Scientists have discovered new evidence that Earth is traveling through clouds of ancient stellar debris left behind by stars that exploded long ago. By studying Antarctic ice that formed tens of thousands of years ago, researchers detected traces of iron-60, a rare radioactive form of iron produced in supernova explosions. This discovery supports the idea that the local interstellar cloud surrounding our solar system contains material from ancient stellar explosions. The study was led by an international team from Dresden-Rossendorf-Helmholtzzentrum (HZDR) and the results were published in the following journals: physical review letter. Rare supernova iron discovered in Antarctic ice…

Read More

It looks like it’s going to be hot in North America this year. According to the National Weather Service’s Seasonal Temperature Outlook for the United States, temperatures are expected to exceed historical averages across the country in June and July. In this environment, 48 men’s national teams will come together to win the World Cup, which will be held in the United States, Canada, and Mexico.As the tournament approaches, The Guardian takes a closer look at the weather conditions players are likely to face, how they have changed since the last time the World Cup was held in North America…

Read More

Four new studies funded by the Ontario Cancer Research Institute (OICR) will deliver cutting-edge innovation by maximizing the impact of existing research and maximizing patient contributions. OICR supports research through CATALYST, a new funding source for research that leverages available patient data and donated samples to advance new insights into cancer detection, diagnosis, and treatment. The first four CATALYST studies, led by Ontario’s top researchers, are examining a wide range of innovative approaches, from blood tests that can predict the likelihood of head and neck cancer recurrence to evaluating whether common diabetes drugs can help prevent blood cancers. All four…

Read More

Researchers at the University of California, Davis have developed a light-driven technology that converts amino acids, the building blocks of proteins, into compounds that behave similar to psychedelics in the brain. These newly created molecules activate serotonin 5-HT2A receptors, which are associated with brain cell growth, and are considered promising targets for treating conditions such as depression, PTSD, and substance use disorders. However, unlike traditional hallucinogens, this compound did not cause significant hallucinogen-like behavior in animal studies. The survey results are Journal of the American Chemical Society. “The question we were trying to answer was, ‘Are there entirely new classes…

Read More

Does your baby put his arms through his sleeves when you dress him? Does your toddler pick up dropped shorts when you sort the laundry? These are examples of how toddlers can be helped by participating in shared activities. As infants reach their first birthday, helping becomes apparent in the context of sharing chores and interactions with caregivers, and fetching objects that are out of reach of unfamiliar adults. Researchers at the Ludwig-Maximilians-University of Munich in Munich, Germany, aimed to address this issue by investigating how infants’ helping behavior is related to motor development, social-cognitive skills, and early interactions with…

Read More

MIT engineers have developed a new method to amplify T cell responses to mRNA vaccines. This progress could lead to more powerful cancer vaccines and stronger protection against infectious diseases. Most vaccines produce both antibodies and T cells that can target vaccine antigens by activating antigen-presenting cells such as dendritic cells. In this study, researchers used a new type of vaccine adjuvant (a substance that helps stimulate the immune system) to boost T cell responses. The new adjuvant is composed of mRNA molecules that encode genes that activate immune signaling pathways and promote exaggerated T cell responses. In studies in…

Read More

Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins. When drug candidate molecules bind to these proteins, they trigger a chemical cascade that changes cell behavior, like a key in a lock. Therefore, understanding how proteins fold and move is essential to developing drugs that interact well with their targets. Artificial intelligence (AI) is a very useful tool for generating new protein structures, but most systems, including Google DeepMind’s AlphaFold, focus on generating static “snapshots” of proteins. Subtle rearrangements of atoms within structures called side chains that affect the protein’s interactions with other molecules are not…

Read More